Reaching for 90:90:90 in Correctional Facilities in South Africa and Zambia: Virtual Cross-Section of Coverage of HIV Testing and Antiretroviral Therapy During Universal Test and Treat Implementation.
dc.contributor.affiliation | Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC. | |
dc.contributor.affiliation | College of Public Health Medicine and Veterinary Sciences, James Cook University, Townsville, Australia. | |
dc.contributor.affiliation | Department of Medicine, Johns Hopkins University, Baltimore, MD. | |
dc.contributor.affiliation | Nossal Institute for Global Health, University of Melbourne, Melbourne, Australia. | |
dc.contributor.affiliation | Department of Family Medicine, School of Medicine, University of Pretoria, Pretoria, South Africa; and. | |
dc.contributor.affiliation | Department of Medicine, Division of Infectious Diseases, School of Medicine, University of Alabama at Birmingham, Birmingham, AL. | |
dc.contributor.affiliation | TB HIV Care, Cape Town, South Africa. | |
dc.contributor.affiliation | The Aurum Institute, Johannesburg, South Africa. | |
dc.contributor.affiliation | School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia. | |
dc.contributor.affiliation | Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom. | |
dc.contributor.author | Hoffmann CJ | |
dc.contributor.author | Herce ME | |
dc.contributor.author | Chimoyi L | |
dc.contributor.author | Smith HJ | |
dc.contributor.author | Tlali M | |
dc.contributor.author | Olivier CJ | |
dc.contributor.author | Topp SM | |
dc.contributor.author | Muyoyeta M | |
dc.contributor.author | Reid SE | |
dc.contributor.author | Hausler H | |
dc.contributor.author | Charalambous S | |
dc.contributor.author | Fielding K | |
dc.date.accessioned | 2025-05-23T11:42:46Z | |
dc.date.issued | 2024-Aug-15 | |
dc.description.abstract | BACKGROUND: People in correctional settings are a key population for HIV epidemic control. We sought to demonstrate scale-up of universal test and treat in correctional facilities in South Africa and Zambia through a virtual cross-sectional analysis. METHODS: We used routine data on 2 dates: At the start of universal test and treat implementation (time 1, T1) and 1 year later (time 2, T2). We obtained correctional facility census lists for the selected dates and matched HIV testing and treatment data to generate virtual cross-sections of HIV care continuum indicators. RESULTS: In the South African site, there were 4193 and 3868 people in the facility at times T1 and T2; 43% and 36% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 1803 (43%) and 1386 (36%) had known HIV status, 804 (19%) and 845 (21%) were known to be living with HIV, and 60% and 56% of those with known HIV were receiving antiretroviral therapy (ART). In the Zambian site, there were 1467 and 1366 people in the facility at times T1 and T2; 58% and 92% were matched with HIV testing or treatment data, respectively. At T1 and T2, respectively, 857 (59%) and 1263 (92%) had known HIV status, 277 (19%) and 647 (47%) were known to be living with HIV, and 68% and 68% of those with known HIV were receiving ART. CONCLUSIONS: This virtual cross-sectional analysis identified gaps in HIV testing coverage, and ART initiation that was not clearly demonstrated by prior cohort-based studies. | |
dc.identifier.doi | 10.1097/QAI.0000000000003456 | |
dc.identifier.uri | https://pubs.cidrz.org/handle/123456789/10724 | |
dc.source | Journal of acquired immune deficiency syndromes (1999) | |
dc.title | Reaching for 90:90:90 in Correctional Facilities in South Africa and Zambia: Virtual Cross-Section of Coverage of HIV Testing and Antiretroviral Therapy During Universal Test and Treat Implementation. |
Files
Original bundle
1 - 1 of 1